Tech Company Financing Transactions
Stuart Therapeutics Funding Round
Stuart Therapeutics, operating out of Stuart, raised $11 million from InFocus Capital Partners, Biobrit and MiMo Capital.
Transaction Overview
Company Name
Announced On
3/24/2021
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Proceeds Purpose
The proceeds from the round will fund Phase 2 clinical trials for the company's proprietary reparative therapeutic candidate, ST-100.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
411 SE Osceola St. 203
Stuart, FL 34994
USA
Stuart, FL 34994
USA
Phone
Website
Email Address
Overview
Stuart Therapeutics was established in 2017 for the development and commercialization of PolyCol, a versatile therapeutic platform that offers a unique tissue reparative approach to a variety of ophthalmic disease indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Schlumpf
Chief Medical Officer
Robert Baratta
Chief Scientific Officer
David Calkins
VP - Bus. Development
Vijay Aggarwal
VP - Bus. Development
Shawn DeLorey
VP - R & D
Brian Buono
Browse more venture capital transactions:
Prev: 3/24/2021: Ro venture capital transaction
Next: 3/24/2021: Akasa venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs